Clinical Trials Browser

Phase 4 × Has results × Lymphoma, Non-Hodgkin × Clear all

NCT01909934 2025-09-19

Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma

Phase 4 Completed

50 enrolled 22 charts

Hematologic Diseases, Lymphoma, Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large-Cell, Anaplastic

NCT02717949 2019-01-08

Optimal

Phase 4 Terminated

Hepatitis C, Liver Diseases, Lymphoma, Non-Hodgkin

NCT00430352 2017-08-14

MAXIMA Study: A Study of Maintenance Therapy With MabThera (Rituximab) in Patients With Non-Hodgkin's Lymphoma.

Phase 4 Completed

545 enrolled 12 charts

Lymphoma, Non-Hodgkin

NCT01164475 2014-02-25

Evaluation of Approved Weight-Based Dose Compared to Fixed Dose of Plerixafor in Patients With Non-Hodgkin's Lymphoma (NHL) Weighing Less Than 70 Kilograms

Phase 4 Completed

61 enrolled 19 charts

Lymphoma, Non-Hodgkin